Derrick Robertson

2.9k total citations
46 papers, 804 citations indexed

About

Derrick Robertson is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Derrick Robertson has authored 46 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 12 papers in Immunology. Recurrent topics in Derrick Robertson's work include Multiple Sclerosis Research Studies (28 papers), Peripheral Neuropathies and Disorders (9 papers) and Immunotherapy and Immune Responses (8 papers). Derrick Robertson is often cited by papers focused on Multiple Sclerosis Research Studies (28 papers), Peripheral Neuropathies and Disorders (9 papers) and Immunotherapy and Immune Responses (8 papers). Derrick Robertson collaborates with scholars based in United States, Germany and Switzerland. Derrick Robertson's co-authors include C J Hawkey, Daniel J. Macey, Sharon McCarthy, Amit Bar‐Or, Edward Fox, Cathy Chognot, Daniela Stokmaier, Jonathan Calkwood, Ann Herman and Marianna Manfrini and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Derrick Robertson

42 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derrick Robertson United States 11 459 235 181 165 137 46 804
Paolo Immovilli Italy 13 378 0.8× 376 1.6× 82 0.5× 392 2.4× 124 0.9× 44 837
Francisco Barriga Chile 17 735 1.6× 121 0.5× 146 0.8× 104 0.6× 521 3.8× 56 1.4k
David L. McGlasson United States 13 96 0.2× 210 0.9× 189 1.0× 27 0.2× 27 0.2× 41 1.0k
Sung Eun Kim South Korea 17 56 0.1× 88 0.4× 77 0.4× 46 0.3× 74 0.5× 102 1.1k
Fabio Bonilla‐Abadía Colombia 12 50 0.1× 74 0.3× 84 0.5× 112 0.7× 21 0.2× 45 476
Michael A. Catalano United States 13 108 0.2× 28 0.1× 346 1.9× 69 0.4× 143 1.0× 45 1.0k
Dominik F. Draxler Australia 14 28 0.1× 112 0.5× 121 0.7× 55 0.3× 49 0.4× 29 744
Anna Hayden Canada 13 80 0.2× 188 0.8× 331 1.8× 309 1.9× 81 0.6× 20 1.2k
Mónica Greco Italy 14 208 0.5× 38 0.2× 206 1.1× 81 0.5× 65 0.5× 24 924
P Madoz Spain 18 36 0.1× 120 0.5× 117 0.6× 33 0.2× 53 0.4× 48 1.2k

Countries citing papers authored by Derrick Robertson

Since Specialization
Citations

This map shows the geographic impact of Derrick Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derrick Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derrick Robertson more than expected).

Fields of papers citing papers by Derrick Robertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derrick Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derrick Robertson. The network helps show where Derrick Robertson may publish in the future.

Co-authorship network of co-authors of Derrick Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Derrick Robertson. A scholar is included among the top collaborators of Derrick Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derrick Robertson. Derrick Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauser, Stephen L., Jeffrey A. Cohen, J. de Sèze, et al.. (2025). Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis. Neurology and Therapy. 14(5). 1975–1992. 2 indexed citations
2.
Mao‐Draayer, Yang, Amit Bar‐Or, John Foley, et al.. (2024). Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients. Advances in Therapy. 42(1). 395–412. 2 indexed citations
3.
Newsome, Scott D., Lawrence Goldstick, Derrick Robertson, et al.. (2024). Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study. Annals of Clinical and Translational Neurology. 11(12). 3215–3226. 2 indexed citations
4.
Álvarez, Enrique, Lawrence Steinman, Edward Fox, et al.. (2024). Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis. Frontiers in Neurology. 15. 1473284–1473284. 1 indexed citations
5.
6.
Robertson, Derrick, et al.. (2023). Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis. International Journal of MS Care. 26(3). 104–107. 4 indexed citations
7.
Hodgkinson, Suzanne, Stephen L. Hauser, Edward Edward, et al.. (2022). 2265 Long-term efficacy of ofatumumab in patients with relapsing multiple sclerosis. Abstracts. A26.2–A26.
8.
Fox, Edward, Lawrence Steinman, Hans‐Peter Hartung, et al.. (2022). Infusion-Related Reactions (IRRs) With Ublituximab in Patients With Relapsing Multiple Sclerosis (RMS): Post Hoc Analyses From the Phase 3 ULTIMATE I and II Studies (P6-4.010). Neurology. 98(18_supplement). 1 indexed citations
9.
Hauser, Stephen L., Edward Fox, Wendy Su, et al.. (2022). Long-term Efficacy of Ofatumumab in Patients With Relapsing Multiple Sclerosis (P5-4.004). Neurology. 98(18_supplement). 3 indexed citations
10.
11.
12.
Benbadis, Selim R., et al.. (2021). Fish soup for the falling sickness: Tracing epilepsy through Hmong and Western beliefs. Epilepsy & Behavior. 115. 107725–107725. 1 indexed citations
13.
Robertson, Derrick, et al.. (2021). Multiple Sclerosis and MyChart Messaging: A Retrospective Chart Review Evaluating Its Use. International Journal of MS Care. 24(6). 271–274. 2 indexed citations
14.
Miravalle, Augusto, Joshua Katz, Derrick Robertson, et al.. (2021). CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis. Neurodegenerative Disease Management. 11(2). 99–111. 6 indexed citations
15.
Giuliani, Fabrizio, Erin E. Longbrake, Yang Mao‐Draayer, et al.. (2020). Immunomodulatory Effects of DMF Treatment on the Peripheral Lymphocyte Compartment: A Focus on Older MS Patients (478). Neurology. 94(15_supplement). 1 indexed citations
16.
17.
Benbadis, Selim R., et al.. (2020). Ceasing Antiquated Conceptions: A Telling of the Early and Evolving History of Epilepsy. European Neurology. 83(3). 341–344. 4 indexed citations
18.
Robertson, Derrick, et al.. (2019). Assessing Barriers to Adherence with the Use of Dimethyl Fumarate in Multiple Sclerosis. Clinical Drug Investigation. 40(1). 73–81. 5 indexed citations
19.
Robertson, Derrick, et al.. (2019). A Rare Complication of Fingolimod: Case Report of Posterior Reversible Encephalopathy Syndrome (P4.2-016). Neurology. 92(15_supplement). 1 indexed citations
20.
Heekin, R. David, et al.. (2015). Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination. Case Reports in Neurology. 7(1). 78–83. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Immovilli Breakdown of academic impact, for papers by Francisco Barriga Breakdown of academic impact, for papers by David L. McGlasson Breakdown of academic impact, for papers by Sung Eun Kim Breakdown of academic impact, for papers by Fabio Bonilla‐Abadía Breakdown of academic impact, for papers by Michael A. Catalano Breakdown of academic impact, for papers by Dominik F. Draxler Breakdown of academic impact, for papers by Anna Hayden Breakdown of academic impact, for papers by Mónica Greco Breakdown of academic impact, for papers by P Madoz
Rankless by CCL
2026